(Q46820258)

25 December 2017

title

Effects of nonselective endothelin-1 receptor antagonism on cardiac mast cell-mediated ventricular remodeling in rats (English)

1 reference

25 December 2017

main subject

mast cell

0 references

ventricular remodeling

1 reference

David B Murray

1

1 reference

25 December 2017

Jason D Gardner

series ordinal

2

1 reference

25 December 2017

Gregory L Brower

series ordinal

3

1 reference

25 December 2017

Joseph S Janicki

series ordinal

4

1 reference

25 December 2017

publication date

4 January 2008

1 reference

25 December 2017

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

25 December 2017

volume

294

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

H1251-7

1 reference

25 December 2017

Endothelin antagonism in pulmonary hypertension, heart failure, and beyond

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Reactive oxygen species generation and histamine release by activated mast cells: modulation by nitric oxide synthase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

The endothelin system and its role in acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Cardiac mast cell-mediated activation of gelatinase and alteration of ventricular diastolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Interruption of endothelin signaling modifies membrane type 1 matrix metalloproteinase activity during ischemia and reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Endothelin-1: a new target of therapeutic intervention for the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Rat cardiac mast cell maturation and differentiation following acute ventricular volume overload.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

The role of endothelins and their receptors in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Contributory role of matrix metalloproteinases in cardiovascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Bosentan, the mixed ETA-ETB endothelin receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Clinical trials of endothelin antagonists in heart failure: publication is good for the public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

The effects of endothelin-1 on degranulation, cytokine, and growth factor production by skin-derived mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Mast cells promote homeostasis by limiting endothelin-1-induced toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Activated mast cells increase the level of endothelin-1 mRNA in cocultured endothelial cells and degrade the secreted Peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Response of cardiac mast cells to atrial natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

A balance between nitric oxide and oxidants regulates mast cell-dependent neutrophil-endothelial cell interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

ET(A)-receptor blockade prevents matrix metalloproteinase activation late postmyocardial infarction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Matrix metalloproteinases: regulation and dysregulation in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Extracellular degradative pathways in myocardial remodeling and progression to heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Role of oxidants in mast cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Rodent and human mast cells produce functionally significant intracellular reactive oxygen species but not nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Recent heart failure trials of neurohormonal modulation (OVERTURE and ENABLE): approaching the asymptote of efficacy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Volume catheter parallel conductance varies between end-systole and end-diastole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Alterations in intracellular reactive oxygen species generation and redox potential modulate mast cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

Effects of chronic endothelin-1 stimulation on cardiac myocyte contractile function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00622.2007

10.1152/AJPHEART.00622.2007

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

18178727

1 reference

25 December 2017